|Extinction of aversive memories associated with morphine withdrawal requires ERK-mediated epigenetic regulation of brain-derived neurotrophic factor transcription in the rat ventromedial prefrontal cortex.|
|PMID: 23035088 Owner: NLM Status: MEDLINE|
|Recent evidence suggests that histone deacetylase (HDAC) inhibitors facilitate extinction of rewarding memory of drug taking. However, little is known about the role of chromatin modification in the extinction of aversive memory of drug withdrawal. In this study, we used conditioned place aversion (CPA), a highly sensitive model for measuring aversive memory of drug withdrawal, to investigate the role of epigenetic regulation of brain-derived neurotrophic factor (BDNF) gene expression in extinction of aversive memory. We found that CPA extinction training induced an increase in recruiting cAMP response element-binding protein (CREB) to and acetylation of histone H3 at the promoters of BDNF exon I transcript and increased BDNF mRNA and protein expression in the ventromedial prefrontal cortex (vmPFC) of acute morphine-dependent rats and that such epigenetic regulation of BDNF gene transcription could be facilitated or diminished by intra-vmPFC infusion of HDAC inhibitor trichostatin A or extracellular signal-regulated kinase (ERK) inhibitor U0126 (1,4-diamino-2,3-dicyano-1,4-bis(methylthio)butadiene) before extinction training. Correspondingly, disruption of the epigenetic regulation of BDNF gene transcription with U0126 or suppression of BDNF signaling with Trk receptor antagonist K252a or BDNF scavenger tyrosine kinase receptor B (TrkB)-Fc blocked extinction of CPA behavior. We also found that extinction training-induced activation of ERK and CREB and extinction of CPA behavior could be potentiated or suppressed by intra-vmPFC infusion of d-cycloserine, a NMDA receptor partial agonist or aminophosphonopentanoic acid, a NMDA receptor antagonist. We conclude that extinction of aversive memory of morphine withdrawal requires epigenetic regulation of BDNF gene transcription in the vmPFC through activation of the ERK-CREB signaling pathway perhaps in a NMDA receptor-dependent manner.|
|Wei-Sheng Wang; Shuo Kang; Wen-Tao Liu; Mu Li; Yao Liu; Chuan Yu; Jie Chen; Zhi-Qiang Chi; Ling He; Jing-Gen Liu|
Related Documents :
|9209828 - Molecular aspects of cannabinoid receptors.
10731038 - Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in ra...
21055418 - Role of the endocannabinoid system in food intake, energy homeostasis and regulation of...
11786148 - Bovine pancreatic secretion in the first week of life: potential involvement of intesti...
22504568 - Cholecystokinin antagonists (part 1): antinociceptive, anxiolytic and antidepressant ef...
15081878 - Functional characterisation of the human alpha1 glycine receptor in a fluorescence-base...
|Type: Journal Article; Research Support, Non-U.S. Gov't|
|Title: The Journal of neuroscience : the official journal of the Society for Neuroscience Volume: 32 ISSN: 1529-2401 ISO Abbreviation: J. Neurosci. Publication Date: 2012 Oct|
|Created Date: 2012-10-04 Completed Date: 2013-01-17 Revised Date: 2014-03-25|
Medline Journal Info:
|Nlm Unique ID: 8102140 Medline TA: J Neurosci Country: United States|
|Languages: eng Pagination: 13763-75 Citation Subset: IM|
|APA/MLA Format Download EndNote Download BibTex|
Association Learning / drug effects, physiology*
Avoidance Learning / physiology*
Brain-Derived Neurotrophic Factor / biosynthesis, genetics*
Butadienes / pharmacology
Chromatin Assembly and Disassembly / drug effects, physiology
Conditioning, Classical / drug effects, physiology
Cyclic AMP Response Element-Binding Protein / physiology
Epigenetic Repression / drug effects, physiology*
Extinction, Psychological / physiology*
Histone Deacetylase Inhibitors / pharmacology
Histones / physiology
MAP Kinase Signaling System / drug effects, physiology*
Morphine / toxicity*
Morphine Dependence / physiopathology*
Nitriles / pharmacology
Prefrontal Cortex / physiology*
Protein Kinase Inhibitors / pharmacology
Protein Processing, Post-Translational / drug effects
Receptor, trkB / antagonists & inhibitors
Receptors, N-Methyl-D-Aspartate / physiology
Substance Withdrawal Syndrome / physiopathology*
|0/Brain-Derived Neurotrophic Factor; 0/Butadienes; 0/CREB1 protein, rat; 0/Cyclic AMP Response Element-Binding Protein; 0/Histone Deacetylase Inhibitors; 0/Histones; 0/Nitriles; 0/Protein Kinase Inhibitors; 0/Receptors, N-Methyl-D-Aspartate; 0/U 0126; 76I7G6D29C/Morphine; EC 184.108.40.206/Receptor, trkB|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Inhibition of protein kinase M? disrupts the stable spatial discharge of hippocampal place cells in ...
Next Document: Analysis of synaptic growth and function in Drosophila with an extended larval stage.